GB201910093D0 - New formulations - Google Patents

New formulations

Info

Publication number
GB201910093D0
GB201910093D0 GBGB1910093.2A GB201910093A GB201910093D0 GB 201910093 D0 GB201910093 D0 GB 201910093D0 GB 201910093 A GB201910093 A GB 201910093A GB 201910093 D0 GB201910093 D0 GB 201910093D0
Authority
GB
United Kingdom
Prior art keywords
new formulations
formulations
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1910093.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Balticgruppen Bio AB
Original Assignee
Balticgruppen Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Balticgruppen Bio AB filed Critical Balticgruppen Bio AB
Priority to GBGB1910093.2A priority Critical patent/GB201910093D0/en
Publication of GB201910093D0 publication Critical patent/GB201910093D0/en
Priority to PCT/GB2020/051692 priority patent/WO2021009504A1/en
Ceased legal-status Critical Current

Links

GBGB1910093.2A 2019-07-15 2019-07-15 New formulations Ceased GB201910093D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1910093.2A GB201910093D0 (en) 2019-07-15 2019-07-15 New formulations
PCT/GB2020/051692 WO2021009504A1 (en) 2019-07-15 2020-07-14 New formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1910093.2A GB201910093D0 (en) 2019-07-15 2019-07-15 New formulations

Publications (1)

Publication Number Publication Date
GB201910093D0 true GB201910093D0 (en) 2019-08-28

Family

ID=67700193

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1910093.2A Ceased GB201910093D0 (en) 2019-07-15 2019-07-15 New formulations

Country Status (2)

Country Link
GB (1) GB201910093D0 (en)
WO (1) WO2021009504A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG177558A1 (en) 2009-07-08 2012-02-28 Baltic Bio Ab 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer

Also Published As

Publication number Publication date
WO2021009504A1 (en) 2021-01-21

Similar Documents

Publication Publication Date Title
GB2584341B (en) Cannabinoid formulations
CA189498S (en) Showerbase
IL287224A (en) Novel formulations comprising melflufen
GB201809976D0 (en) Novel formulations
GB201904338D0 (en) Fluorouracil-containing formulations
IL290447A (en) Pharmaeutical composition comprising ensifentrine
CA187781S (en) Banquette
GB201901778D0 (en) Aladin
IL284688A (en) Formulation
PT4045038T (en) New formulations
CA189673S (en) Uroflowmeter
IL290356A (en) Larazotide formulations
IL284691A (en) Formulations
GB201913232D0 (en) Aerosolisable formulation
GB201910092D0 (en) New formulations
GB201910093D0 (en) New formulations
GB201911063D0 (en) Formulations
GB201905105D0 (en) Formulations
SG11202011823SA (en) Activator-nucleator formulations
GB202117828D0 (en) New formulations
GB2587402B (en) Formulation
GB201819028D0 (en) Butanol-based formulations
CA195219S (en) Overall
GB201808386D0 (en) Formulations
GB201804545D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)